ArticleThe New England journal of medicine2015
Reducing LDL with PCSK9 Inhibitors--The Clinical Benefit of Lipid Drugs.
Brendan M Everett et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
60 papers cite it
this paperpooled ittrialcites it
ArticleThe New England journal of medicine2015
Brendan M Everett et al.PubMed ↗Publisher ↗
No numbers read from the abstract.